StockNow
Log in
U.S. Markets

AbbVie (ABBV) confirms it is to acquire Apogee Therapeutics (APGE)

News detail

Under the terms of the transaction, AbbVie will acquire all outstanding shares of Apogee for USD 135.11/shr in cash.  The transaction values Apogee at a total equity value of approximately USD 10.9bln.  The boards of directors of both companies have unanimously approved the transaction.  This transaction is expected to close in the third quarter of 2026, subject to customary closing conditions, including Apogee shareholder approval and receipt of regulatory approvals.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

U.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)